Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D AMSTERDAM

Showing results (251-260 of 265) with videos related to

Pageof 27
Sort By:
The American Journal of Psychiatry|August 18, 1999
Changes in weight during a 1-year trial of fluoxetineD Michelson, J D Amsterdam, F M Quitkin, et al.
The American Journal of Psychiatry|September 12, 1998
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatmentF W Reimherr, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depressionP J McGrath, J W Stewart, E Petkova, et al.
The Journal of Clinical Psychiatry|May 4, 2007
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled studyDavid Michelson, Lenard A Adler, Jay D Amsterdam, et al.
Journal of Affective Disorders|February 16, 2008
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapySunil S Bhar, Lois A Gelfand, Sabine P Schmid, et al.
Immunological Investigations|January 1, 1997
Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipientsM J Evans, Y Edwards-Spring, J Myers, et al.
Neuroimmunomodulation|February 6, 2004
Neuroendocrine aspects of chronic fatigue syndromeDimitris A Papanicolaou, Jay D Amsterdam, Susan Levine, et al.
Archives of General Psychiatry|April 6, 2005
Prevention of relapse following cognitive therapy vs medications in moderate to severe depressionSteven D Hollon, Robert J DeRubeis, Richard C Shelton, et al.
Neuroimmunomodulation|October 7, 2004
Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of HealthTimothy R Gerrity, Dimitris A Papanicolaou, Jay D Amsterdam, et al.
Pageof 27

Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
The American Journal of Psychiatry|August 18, 1999
Changes in weight during a 1-year trial of fluoxetineD Michelson, J D Amsterdam, F M Quitkin, et al.
The American Journal of Psychiatry|September 12, 1998
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatmentF W Reimherr, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depressionP J McGrath, J W Stewart, E Petkova, et al.
The Journal of Clinical Psychiatry|May 4, 2007
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled studyDavid Michelson, Lenard A Adler, Jay D Amsterdam, et al.
Journal of Affective Disorders|February 16, 2008
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapySunil S Bhar, Lois A Gelfand, Sabine P Schmid, et al.
Immunological Investigations|January 1, 1997
Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipientsM J Evans, Y Edwards-Spring, J Myers, et al.
Neuroimmunomodulation|February 6, 2004
Neuroendocrine aspects of chronic fatigue syndromeDimitris A Papanicolaou, Jay D Amsterdam, Susan Levine, et al.
Archives of General Psychiatry|April 6, 2005
Prevention of relapse following cognitive therapy vs medications in moderate to severe depressionSteven D Hollon, Robert J DeRubeis, Richard C Shelton, et al.
Neuroimmunomodulation|October 7, 2004
Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of HealthTimothy R Gerrity, Dimitris A Papanicolaou, Jay D Amsterdam, et al.
Pageof 27